OpenEvidence is free for now. Its CEO has a plan for who will pay

Doctors across America are rapidly adopting the medical AI platform OpenEvidence, a free chatbot that answers medical questions.

Doctors across America are rapidly adopting OpenEvidence, a free AI-powered chatbot that relies on peer-reviewed literature to answer medical questions. But its CEO, Daniel Nadler, says the model that made OpenEvidence ubiquitous — free for doctors, paid for by ads from pharmaceutical companies and others — may not be the one that the company wants to take into the future.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

Just a moment.

We are getting your experience ready.